# Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET

> **NCT02261389** · NA · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 1507 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Arm B, tumor markers assessment

## Key facts

- **NCT ID:** NCT02261389
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-09
- **Primary completion:** 2026-11
- **Final completion:** 2030-12
- **Target enrollment:** 1507 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02261389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02261389, "Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02261389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*